SG3 Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-20,000
Closed -$240K 1401
2020
Q4
$240K Sell
20,000
-5,000
-20% -$59.1K ﹤0.01% 847
2020
Q3
$250K Buy
+25,000
New +$301K 0.01% 694
2017
Q4
Sell
-14,000
Closed -$907K 178
2017
Q3
$907K Hold
14,000
0.21% 77
2017
Q2
$758K Hold
14,000
0.19% 116
2017
Q1
$781K Buy
+14,000
New +$736K 0.14% 105

Other funds holding PRTA

SG3 Management's PRTA Position: Q2 2021 in Review

SG3 Management sold out of Prothena Corp (PRTA) in Q2 2021, closing a stake of 22,500 shares — an estimated $565K sold.

SG3 Management first reported a position in PRTA in Q1 2017 and held it in 5 quarters. The position peaked at $565K in Q1 2021. 156 funds tracked by Wall St. Rank hold PRTA as of Q2 2021.

  • SG3 Management reported no remaining Prothena Corp position as of Q2 2021 after selling out during the quarter.
  • SG3 Management sold 22,500 Prothena Corp shares in Q2 2021, an estimated $565K.
  • SG3 Management first reported a position in Prothena Corp in Q1 2017 and held it in 5 quarters.
  • SG3 Management's Prothena Corp position peaked at $565K in Q1 2021.
  • 156 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2021.

Based on SG3 Management's 13F filing for Q2 2021, filed 16 Aug 2021.